All posts by imreal

Fragmented BCMO Market Pressured by Economic and Pharmaceutical Industry Factors


Through the five year forecast period of Kalorama’s report, a variety of economic and pharmaceutical industry factors will intensify the pressure on drug developers.

The global biopharmaceutical contract manufacturing organization (BCMO) industry is highly fragmented, with 40 BCMOs/CDMOs accounting for roughly one quarter of the industry’s revenues and the remainder comprised of a large number of smaller players. Based upon 2021 figures, Catalent led the overall market with estimated BCMO sales of $2.2 billion It was followed closely by Cytiva with $2.0 billion While these market leaders are active in most of the geographic market segments, smaller players tend to focus on a few regions, particularly the U.S. and/or Western Europe. Besides market leaders, companies of interest include Dr. Reddy’s as well as WuXi AppTec, Pfizer CentreOne, Baxter. This is according to Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, Kalorama’s latest report on the sector.

It should be noted that most of these companies do not separate their contract manufacturing from their contract research and development revenues; they also do not separately report their small molecule versus large molecule revenues. Therefore, these figures represent estimates based upon report information and industry averages.

“Future Market Trends”

Many factors have impacted global drug makers in recent years. These trends, which are well established, are expected to continue through the next several years. Additionally, ongoing economic challenges will further pressure the industry, making drug maker financial performance even more important and tightening access to capital for smaller players.

Through the five year forecast period of this report, a variety of economic and pharmaceutical industry factors will intensify the pressure on drug developers, including:


  • Tight lending policies from risk averse banks and financiers;
  • uncertainty within the corporate sector on healthcare and other costs;
  • rising requests of drug makers to offer rebates and discounts on medications;
  • ongoing patent expirations fueling a strong need for new product candidates;
  • a high level of regulatory scrutiny across the drug lifecycle from testing and approval to manufacturing and marketing;
  • new imperatives to contain spending and/or cut costs to improve reported performance, particularly focusing on manufacturing as it represents a high fixed cost asset;
  • constrained internal manufacturing staff and capabilities in some areas, following prior downsizings coupled with continued high excess manufacturing capacity amongst other pharmaceuticals and BCMOs.

While all of these factors are important, the impact of the economic pressures cannot be overstated since many drug makers are publicly traded and financial pressures directly impact their budgets. In this environment, manufacturers will be extremely cautious about investments in new technologies, equipment or facilities, preferring to outsource to established experts rather than incur heavy capital costs building, expanding or upgrading their own internal capabilities. This is particularly true for mid size and emerging drug makers, whose resources are limited compared with the larger drug makers. This will have the net effect of stimulating contract manufacturing, although it will also increase pricing pressure on service providers and result in more risk sharing and other innovative agreements between sponsor and contractor.

Predicting the shape of the global drug manufacturing landscape in the long term necessarily involves a higher degree of uncertainty, particularly related to the state of regional economies. However, as of mid-2022, most analysts were optimistic about the healthcare sector.

Share article on social media or email:

South Florida Sedation Dentistry Announces Launch Of New Website


South Florida Sedation Dentistry

South Florida Sedation Dentistry in West Palm Beach, FL

Our new website will help us better educate patients about the services we provide and the benefits of sedation dentistry for those who are anxious or scared about coming to the dentist.

South Florida Sedation Dentistry is announcing the launch of its new and improved website, https://www.southfloridasedationdentistry.com. The website has been redesigned to be more user-friendly, with core features that allow patients and visitors to get a wealth of information about the benefits of sedation dentistry and the other dental services offered in a quick and easy format. The website features a patient portal, which allows patients to easily access patient forms and communicate with their dentist through email. It also has testimonials from past and current patients as well as a Smile Gallery that showcases some of the smile makeovers performed by Dr. Senft and his dental team.

South Florida Sedation Dentistry is led by Mitchel Senft DMD, DICOI, a graduate of the Washington University Dental School and the Misch Implant Institute. As an accomplished and well-respected dentist, Dr. Senft is also a Diplomat of the International Congress of Oral Implantologists and a Fellow with the Misch Institute, his team of dental health professionals who are dedicated to providing a positive experience when it comes to dental care.

“The website is the first stop for most individuals seeking treatment, so it’s important it provides an informative and engaging experience,” said Dr. Mitchel Senft, founder and owner of South Florida Sedation Dentistry. “Our new website will help us better educate patients about the services we provide and the benefits of sedation dentistry for those who are anxious or scared about coming to the dentist.”

South Florida Sedation Dentistry is a leading provider of a range of dentistry services including implant, general, cosmetic, emergency, and sedation dentistry in South Florida. The practice offers a range of sedation options, including nitrous oxide, oral conscious sedation, and IV sedation. South Florida Sedation Dentistry is experienced in treating patients with fear or anxiety regarding dental work who would otherwise likely avoid the dentist altogether.

The practice offers a wide range of dental services including:

  • General dentistry: In addition to services like cleanings and fillings, general dentistry also includes scaling and root planing for gum disease, root canals, and gum grafting
  • Cosmetic dentistry: Cosmetic dentistry focuses not just on the health of teeth and gums but also the appearance. It includes crowns and bridges, soft tissue recontouring, and full smile reconstruction.
  • Dental implants: South Florida Sedation Dentistry uses the latest technology for dental implants to get the highest level of accuracy when implants are placed.
  • Dental emergencies: The practice offers 24/7 emergency dental care for problems that require immediate treatment including chipped teeth, broken teeth, teeth that have been knocked out, infected or abscessed
  • Sedation dentistry: Dr. Senft offers IV sedation for the above-mentioned services for those that are anxious or scared at the dentist.

About South Florida Sedation Dentistry

South Florida Sedation Dentistry is a full-service dental practice located in West Palm Beach, FL and is led by Dr. Mitchel Senft. To schedule an appointment, call 561-967-2001 or request an appointment online. South Florida Sedation Dentistry is located at 6633 Forest Hill Blvd, West Palm Beach, FL 33413.

Share article on social media or email:

CommunityMed Family Urgent Care Now Welcomes Patients in Mansfield


The south part of DFW has been booming with growth, which means there are more people that need reliable, convenient healthcare services there. To make sure people can get the care they need, we opened the Mansfield clinic, and we’re planning to join the Midlothian community in early 2023, too.

CommunityMed Family Urgent Care, a locally owned and operated healthcare provider, is treating patients in its newest clinic in Mansfield, which opened mid-September. The practice provides urgent care, COVID-19 testing and occupational medicine services. From boo-boos and broken bones to sniffles and aches, the clinic is the ideal place for people to receive treatment for injuries or illnesses that need to be addressed quickly but are not serious enough to require emergency room care or hospitalization.

CommunityMed has had its eye on the Mansfield area for some time, noticing the population surge and need for urgent healthcare services.

“The south part of DFW has been booming with growth, which means there are more people that need reliable, convenient healthcare services there,” said Birken Olson, the CEO of CommunityMed. “To make sure people can get the care they need, we opened the Mansfield clinic, and we’re planning to join the Midlothian community in early 2023, too.”

CommunityMed is known for its innovation and agility. It was one of the first DFW healthcare providers to offer seamless virtual waiting rooms and rapid PCR tests early in the pandemic, giving patients a modern and safe experience during a tumultuous time. The organization continues to provide COVID-19 testing where anyone can request a rapid PCR test and receive written documentation of their lab results on for work, school or travel. The clinics also provide COVID-19 blood-antibody tests.

The healthcare provider is a highly trusted resource in the occupational medicine space after establishing its program in early 2019. CommunityMed’s new clinics offer services such as workplace injury care, physicals, customized pre-employment exams, vaccinations, DOT physicals, drug screens and breath alcohol testing.

CommunityMed accepts most major insurance providers, including Medicare and Tricare, as well as cash payments. Patients should always call their insurance provider to verify benefits.

The Mansfield location’s phone number is (682) 282-4014 and its address is 3020 E. Broad St. Suite 100, Mansfield, TX 76063. It is on East Broad Street across from Mansfield High School and next to the Chipotle. For more information or to register online, visit https://communitymedcare.com/mansfield-urgent-care/

About CommunityMed

CommunityMed Urgent Care, based in Dallas, operates walk-in medical clinics throughout North Texas in smaller towns in the North Texas region. With clinics in Arlington, Cross Roads, Haslet, Heath, Lantana, Mansfield, McKinney, Melissa, Princeton, Prosper, Southlake and Wichita Falls, CommunityMed offers first-class service, top quality care and a hometown spirit. The company has also been named to the Dallas 100 list of fastest-growing private companies by the SMU Cox Caruth Institute for Entrepreneurship for four years running. Visit the company website at CommunityMedCare.com.

Share article on social media or email:

HearingLife Celebrates the Holiday Season With “Hear the Magic. Love Your Ears.” Campaign


“Our Give Back campaign at HearingLife, will offer people the opportunity to gain back a renewed sense of self and the ability to participate fully in the joys of the season.”

HearingLife, a leader in delivering life-changing hearing care, today announced the kickoff of its “Hear the Magic. Love Your Ears.” holiday campaign* accompanied by the second annual “Magic of Giving Back” give back program aimed to help those with hearing loss gain back the joyful sounds of the holiday season. From a Harris Poll survey, 72% of people with hearing loss wish their hearing was better to enjoy holiday and special gatherings.+

Our hearing is a pivotal part of feeling connected to the people and things we love most in our lives, and HearingLife understands the struggle those with hearing loss experience during celebratory moments and holiday gatherings. Through the “Magic of Giving Back” program, HearingLife will give free hearing aids to six people in need with hearing loss. Starting today, October 4, 2022 through November 12, 2022, anyone in the US can submit their story through http://www.HearingLife.com/Magic.

“I’m so proud of this effort and how the HearingLife team impacted the lives of these customers during a particularly important, though often hard, season for those with hearing loss,” says Dean Pappous, HearingLife President. “After receiving so many heartwarming stories through last year’s campaign, we knew we had to continue this important tradition. Our continued support of this campaign will help these individuals – and their families – see all that there is to gain for years to come.”

In addition to the Holiday Give Back campaign, since 2018, HearingLife has supported “Campaign For Better Hearing” – a year-round give back program where hearing care providers recommend free hearing aids for patients who cannot afford them. Through “Campaign for Better Hearing,” HearingLife provides over 80 free pairs of hearing aids each year.

“Individuals with hearing loss may experience feelings of embarrassment or frustration when they can’t hear or participate in conversations,” said Dr. Leslie Soiles, Chief Audiologist, HearingLife. “Often, this can cause them to stop socializing or participating in events or activities that they used to enjoy. Our Give Back campaign at HearingLife, will offer people the opportunity to gain back a renewed sense of self and the ability to participate fully in the joys of the season.”

For the opportunity to receive free hearing aids through the “Magic of Giving Back,” anyone in the US can submit their personal story, or a story on behalf of a loved one, explaining why they are a potential candidate for the HearingLife Magic of Giving Back program. To learn more and share your story, visit http://www.HearingLife.com/Magic.

About HearingLife

HearingLife is a national hearing care company and part of the Demant Group, a global leader in hearing healthcare built on a heritage of care, health, and innovation since 1904. HearingLife operates nearly 700 hearing care centers across 42 states. We follow a scientific, results-oriented approach to hearing healthcare that is provided by highly skilled and caring professionals. Our vision is to help more people hear better through life-changing hearing health delivered by the best personalized care. To learn more, visit: https://www.hearinglife.com.

*Terms & Conditions apply

Visit http://www.HearingLife.com/Magic to learn more

+Survey Method:

This survey was conducted online within the United States by The Harris Poll on behalf of HearingLife from August 19-23, 2021, among 2,044 adults ages 18+, among whom 253 have hearing loss. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact hearinglife@kaplow.com.

For more information please contact:

HearingLife@kaplow.com

Share article on social media or email:

Greenspring Medical Aesthetics in Tucson, AZ is Hosting a CoolEvent on Nov. 5, Offering Event-Only Specials on CoolSculpting®


Young smiling fitness woman wearing sportswear standing over white wall background

Greenspring Medical Aesthetics in Tucson, Arizona is having a CoolEvent on Nov. 5, offering event-only discounts on CoolSculpting®.

Everyone is welcome to come by Greenspring Rejuvenation Medical Aesthetics to take advantage of event-only specials.

Greenspring Medical Aesthetics in Tucson, Arizona is hosting a CoolEvent on Nov. 5, offering event-only savings on FDA-cleared CoolSculpting®, the world’s no. 1 non-invasive fat reduction treatment. Everyone is welcome to come by Greenspring Rejuvenation Medical Aesthetics to take advantage of event-only specials. Here are the event details, for those who are interested:

SAVE THE DATE AND SAVE BIG

  •     Saturday, Nov. 5 – Greenspring Rejuvenation Medical Aesthetics
  •     2870 East Skyline Drive #100, Tucson, AZ 85718

Buy 4 CoolSculpting Treatments, Get 50% off PLUS 2 FREE Treatments

Buy 6 or more CoolSculpting Treatments, Get 50% off PLUS 2 FREE Treatments

Attendees will enjoy:

  •     Event-only discounts on CoolSculpting
  •     CoolSculpting demonstration

Those interested in attending must call ahead to reserve a time. Call 520.529.9665 today to RSVP!

Greenspring Medical Aesthetics is Tucson’s premier medical aesthetics and anti-aging center, with Greenspring Rejuvenation and Greenspring Oasis located in Tucson, AZ and Greenspring Inspire located in Oro Valley, AZ. To learn more or schedule a consultation at any Greenspring location, please call 520.529.9665 or visit https://greenspringaesthetics.com/ today.

About Greenspring Medical Aesthetics

Greenspring Medical Aesthetics specializes in face and body rejuvenation using only non and minimally invasive procedures. Greenspring promotes a non-surgical approach to beautiful skin and body symmetry with many options for non-surgical facelifts and neck lifts, as well as for body contouring.

Greenspring Medical Aesthetics offers more highly effective non-surgical options for their patient’s problem areas than any other provider in Southern Arizona. Services include Botox®, Xeomin®, Dysport®, Juvedérm®, Restylane®, Radiesse®, Kybella®, Ultherapy®, Silhouette Instalift, Plasma Pen, PRP, CoolSculpting®, Cellfina®, Clear + Brilliant®, IPL photofacial, chemical peels, microdermabrasion, acne treatments and more. Greenspring Medical Aesthetics also carries physician-level skin care. For more information, please call 520.529.9665 or visit https://greenspringaesthetics.com/.

About Dr. Alexander P. Cadoux, Aesthetic Physician

Alexander P. Cadoux specializes in beauty and is nationally known for his extraordinary results in erasing the lines of time. Dr. Cadoux has built his aesthetic medicine practice on artistry, experience and value. At Greenspring, Dr. Cadoux will personally perform your injectable and cosmetic procedures giving you the result you want.

Dr. Cadoux has more than 28 years of experience in cosmetic and laser medicine. After receiving his medical degree from Johns Hopkins Medical School, Dr. Cadoux began his postgraduate residency training. His residency included training at Johns Hopkins Hospital, Georgetown University Hospital, George Washington University Hospital and Maryland Shock Trauma.

Dr. Cadoux is known as an authority in his field for his advanced techniques and long-lasting natural wrinkle correction and lip enhancement procedures. He specializes in the face and neck, using his remarkable expertise when doing nonsurgical, office-based liquid facelifts and facial sculpture.

About Dr. Kathleen P. Nichols, Aesthetic Physician and Medical Director of Greenspring Oasis

Kathleen P. Nichols has more than 14 years of experience in cosmetic medicine. Dr. Nichols graduated as an undergraduate from the University of Washington and graduated from the University of Washington School of Medicine. She completed her residency at the University of California San Diego and completed a fellowship at the University of Washington School of Medicine.

Dr. Nichols was also a professor at the University of California at San Diego School of Medicine. She has practiced in Tucson since 1992 and is currently the Medical Director of Greenspring Oasis Medical Aesthetics.

Share article on social media or email:

Crisis Prevention Institute Introduces Workplace Violence Prevention Handbook for Health Care Professionals to Help Reduce Workplace Violence


“We created the Workplace Violence Prevention Handbook to give health care professionals the easiest and most effective first step they can take toward creating a peaceful, non-violent workplace that is safe for everyone.”

Today, Crisis Prevention Institute (CPI), the worldwide leader in evidence-based de-escalation and crisis prevention training, published its new Workplace Violence Prevention Handbook for Health Care Professionals. This free resource is designed to provide easy-to-use recommendations and strategies to help individuals in all levels and roles of health care improve their workplace violence prevention programming to generate immediate results.

The Workplace Violence Prevention Handbook for Health Care Professionals can be downloaded at crisisprevention.com/handbook. Its stand-alone chapters are written to help health care leaders and workplace violence committee members make immediate enhancements for any pain point they are experiencing related to workplace violence. The book is the first of its kind in the health care crisis prevention field and was developed by qualified individuals who are trained in crisis prevention, with more than 150 total years of experience working in health care.

“Health care professionals continue to face a rising tide of violence in the workplace,” said Susan Driscoll, president, CPI. “The increase in violence is creating unsustainable challenges, including physical harm to workers, rising numbers of dedicated professionals leaving the field to which they were called, and greater difficulty providing effective patient care.”

According to recent surveys of nurses by Hospital IQ, 90% of respondents are considering leaving the nursing profession in the next year and 72% said they were experiencing burnout long before the pandemic. Overall, 77% of health care workers believe workplace violence is a priority and more than two-thirds report experiencing more serious mental health issues like anxiety or depression as a result.

“The health care organizations we speak with need help identifying what to do and how to do it, and they need it fast,” said AlGene P. Caraulia, vice president of Integration and Sustainability, CPI. “We created the Workplace Violence Prevention Handbook to give health care professionals the easiest and most effective first step they can take toward creating a peaceful, non-violent workplace that is safe for everyone. With this free download they can review, learn, and adopt research-based strategies and methods that will improve their workplace violence prevention programs.”

The Workplace Violence Prevention Handbook for Health Care Professionals provides a major step forward in helping health care organizations dedicated to creating a safer, more peaceful environment for workers, patients and visitors. It can be used to enhance and complement current workplace violence prevention plans and, when paired with CPI’s training programs, provides health care organizations a clear path to the organizational change and accountability required to de-escalate traumatic situations, reduce risk and violence, and create a safer workplace.

The handbook is intended to meet an organization where it is in its workplace violence prevention mission, helping health care professionals better understand how to:

· Build or improve workplace violence prevention programs

· Respond internally to incidents of workplace violence

· Gather, measure and manage data to analyze challenges unique to any organization

· Manage training and education needs at all levels of health care organizations, including multi-site hospitals and health systems, clinics, outpatient care and surgery centers

· Build a holistic culture of violence prevention

· Balance workplace violence prevention programming with patient advocacy and staff support

Since 1980, CPI has helped train more than 15 million people within service-oriented industries and has served its field longer than anyone else. By successfully diagnosing, designing, and implementing thousands of workplace violence prevention programs across the globe, CPI has helped its clients review, reassess, and reinvest in their workplace violence prevention programs to help entire teams, including those in the c-suite, human resources, security, nursing, and more, believe in and take ownership of their workplace violence prevention committees and initiatives.

About Crisis Prevention Institute

Crisis Prevention Institute is a world-leading training organization specializing in the safe management of disruptive and assaultive behavior. The Company’s Nonviolent Crisis Intervention® training program is embraced worldwide by organizations committed to providing quality care and services in a respectful, safe environment. The strategies taught in the Nonviolent Crisis Intervention® training program provide staff members with an effective framework for decision making and problem solving to prevent, de-escalate, and safely respond to disruptive or assaultive behavior. The philosophy relating to Care, Welfare, Safety, and SecuritySM expands throughout the continuum of interventions that are necessary when working toward reduction or elimination of restraint use.

Share article on social media or email:

The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology


News Image

“This checklist provides investigators, and other key stakeholders, a roadmap to identify and prioritize phase III clinical trials that are likely to offer the greatest benefit to patients.” said SITC President Patrick Hwu, MD

No uniform method has been established to predict the probability of success for individual clinical trials. To help identify clinical trials with a high likelihood of offering benefit to patients, the Society for Immunotherapy of Cancer (SITC) brought together a team of experts in immuno-oncology to create a conceptual framework for potential value in phase III studies evaluating immunotherapy combinations. The framework, put forth as a checklist for the oncology community, is published in a new manuscript, “Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC),” now available in the Journal for ImmunoTherapy of Cancer, the society’s open-access, peer-reviewed online journal.

“Immuno-oncology clinical trials are of the utmost importance to provide new effective drugs for cancer patients,” said SITC President Patrick Hwu, MD. “This checklist provides investigators, and other key stakeholders, a roadmap to identify and prioritize phase III clinical trials that are likely to offer the greatest benefit to patients.”

Phase III trials are how new treatments for cancer demonstrate benefit and establish their place in the treatment paradigm to offer improved outcomes for patients. These trials are time- and resource-intensive, involving hundreds of patients and spanning multiple years. As many as half of phase III trials in oncology are unsuccessful, representing substantial losses in terms of monetary investment and opportunity for patients to receive a more effective treatment for their disease.

Clinical trials evaluating immunotherapy combinations have proliferated in recent years as immunotherapy has become the standard of care for the treatment of many cancers, offering some patients long-term remissions and even cures. Despite many successes, several recent trials of immunotherapy combinations have failed to show improvement over current treatments.

“Immunotherapy is radically different from conventional cancer treatments such as chemotherapy, which are based on directly attacking the tumor itself” says Michael B. Atkins of Georgetown Lombardi Cancer Center, the checklist manuscript’s first author. “Because immunotherapy treats a patient’s immune system to enable it to eliminate the tumor, phase III trials for immunotherapy combinations should consider, among many factors, the impact of the combinations on antitumor immunity and be designed with immune endpoints in mind.”

SITC’s checklist provides a simple framework to evaluate the mechanism and biology, early clinical evidence, trial design, and potential for impact of planned phase III trials evaluating immunotherapy combinations. The checklist places the highest priority on clinical data, and in cases where this is lacking, evidence of anti-tumor activity in multiple pre-clinical models, a well-defined immune mechanism of action, and a predictive biomarker to allow for selection of patients are strongly encouraged.

The release of this checklist comes on the heels of additional action SITC has brought about to address an ongoing crisis in clinical research encompassing a multitude of factors, including clinical trial administrative staffing shortages, administrative burdens, and inadequacy of current business models. The checklist may be useful to investigators in prioritizing phase III trials in response to potential overall reductions in accrual and/or increases in the number of phase III trials relative to the institution’s capacity for accrual. SITC has been leading many efforts to address the crisis, along with the checklist, to create solutions to help resolve the challenges facing the issues around clinical trials. For more information on these efforts, visit the SITC Crisis in Clinical Research web page.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn and YouTube.

Share article on social media or email:



Cognosante’s Customer Experience Business Sector to Support CMS Enrollment Assistance Program for Medicaid Unwinding


Cognosante’s customer experience (CX) business sector, CognoConnected, has been awarded the Enrollment Assistance Program (EAP) for Medicaid Unwinding contract by the Centers for Medicare & Medicaid Services (CMS). The 19-month contract has an approximate value of $21 million.

Cognosante will support the CMS Center for Consumer Information and Insurance Oversight (CCIIO) in ensuring continuity of coverage for individuals and families impacted by the Medicaid Unwinding at the end of the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE). Cognosante will provide outreach and impartial, free, in-person and virtual enrollment assistance to impacted consumers in multiple states, facilitating their seamless transition into a Qualified Health Plan (QHP) through the Federally Facilitated Marketplace (FFM).

Following the end of the PHE, states must conduct Medicaid and Children’s Health Insurance Program (CHIP) eligibility redeterminations for beneficiaries. Many beneficiaries have remained on Medicaid and CHIP throughout the COVID-19 pandemic due to the continuous enrollment condition authorized by the Families First Coronavirus Response Act (FFCRA). As a result, a large volume of beneficiaries across the country who are determined to no longer be eligible for Medicaid or CHIP, or fail to respond to the redetermination requests, could face a loss of health insurance coverage.

To help these impacted consumers smoothly transition from Medicaid or CHIP to enrollment into QHPs – also referred to as Medicaid Unwinding – Cognosante will provide trained local support teams in designated states to help consumers and their families navigate the Healthcare.gov application process and make informed health coverage decisions. Cognosante will collaborate with local community organizations to maximize outreach efforts and engage directly with the enrolling community where they live and work.

According to CMS, Medicaid Unwinding presents the single largest health coverage transition since the first open enrollment period of the Affordable Care Act (ACA).“The Cognosante team will bring to bear the full depth and breadth of our customer experience expertise to support CMS’ mission of ensuring continuity of coverage for eligible consumers,” said Anita Griner, General Manager of Cognosante’s customer experience business sector.

Cognosante supported CMS in a similar EAP during implementation of the Affordable Care Act. In addition, Cognosante was recently awarded the CMS No Surprises Help Desk contract, which intends to protect individuals from surprise medical bills for emergency services, air ambulance services furnished by nonparticipating providers, and non-emergency services furnished by nonparticipating providers at participating facilities in certain circumstances.

About Cognosante

Cognosante is a mission-driven technology company delivering innovative and transformative solutions that improve the health and safety of Americans. With more than a decade of experience working with Federal and state government agencies, we aim to expand access to care, improve care delivery, deliver solutions addressing social determinants of health, and ensure safety and security through multi-faceted technology and customer experience (CX) solutions. Our broad range of capabilities includes enterprise IT and cloud, data science, telehealth, interoperability, public health surveillance, clinical performance, eligibility and enrollment, and consumer engagement. For more information, visit http://www.cognosante.com

Share article on social media or email:

West Texas A&M University Student Wins SignatureCare Emergency Center’s 2022 Fall Semester Medical and Health Scholarship


SignatureCare Emergency Center, Montrose, Houston, TX

SignatureCare Emergency Center, Montrose, Houston, TX

Psychiatry and Neurology became topics I researched outside of school. I became fascinated with how specialists in these fields could identify and treat developmental, mental, and behavioral disorders. I began dreaming of medical school and a career in these fields.

SignatureCare Emergency Center has awarded its 2022 fall semester Medical and Health Scholarship to West Texas A&M University Biology Pre-Med and Psychology junior Michelle Truong.

Michelle was chosen by our panel of judges to receive the $1,000 scholarship award.

SignatureCare Emergency Center gives this semi-annual scholarship award to qualified U.S. college students who demonstrate passion and commitment to the healthcare field. The scholarship award is designed to help the students pay for tuition, room and board, books, and other school-related expenses.

While receiving the award, Michelle thanked SignatureCare for the award, adding that the scholarship will enable her to pursue her degree, and afford the cost of applying to various medical schools.

“Thank you for giving me this scholarship. This scholarship will enable me to continue to pursue my degree in Biology and Psychology. I will be applying to medical schools as a pre-med student so that I can become a full-fledged medical doctor and give back to my community and those who have supported me.

“With this scholarship, I will be able to afford schooling and apply to medical schools as those can get very expensive. Thank you so much for this opportunity,” she added.

Ms. Truong said her mother’s medical issues informed her decision to become a medical doctor.

“My mother was diagnosed with bipolar depression when I was eight. I became the target of her anger shortly after. She often shifted between despising my existence and singing me praises. She often had fits of depression and mania, and would verbally assault me to make herself feel better.

“She always came to apologize afterward. From telling me to kill myself to abandoning me in far-away parking lots, my life with my mother was confusing. I constantly walked on eggshells around her. As I grew older, I started to understand that it was her mind that made her so confused. However, despite my mother being my biggest abuser, she was the reason I decided to pursue medicine.

“Mom was an immigrant from Saigon, Vietnam, who had a load of generational trauma. The problem was that in our culture, seeking mental help was frowned upon, making my mom against seeking help. She refused to take her medication and labeled anyone who took antidepressants and mood stabilizers a psychopath.

“I, on the other hand, wanted to understand what my mother was so against. I started studying my mother’s behavior to cope with her abuse. I researched medicine to see how these little pills would help someone’s mind stabilize. This is where my interest in medicine began.

“Psychiatry and Neurology became topics I researched outside of school. I became fascinated with how specialists in these fields could identify and treat developmental, mental, and behavioral disorders. I began dreaming of medical school and a career in these fields.

“The most unsupportive person I have in my life became my gateway into medicine. I was inspired by the work that Psychiatrists and Neurologists do for patients, even if they refuse treatment like my mother. When I entered college, I was afraid of pursuing medicine because of the limitations I put on myself. But now, I am determined to make my dream a reality. Hopefully, in medical school, I will study more in these fields.

“As a doctor, I hope to help people within my community of Asian Americans. I want to help reverse the generational trauma among these individuals and shine a positive light on mental and emotional health. I will do this by learning to more fluently speak Chinese and Vietnamese while advertising myself to the Asian-American community,” she added.

Rhonda Abbe, Director of Operations for SignatureCare Emergency Center, congratulated Michelle for winning the scholarship.

“Michelle has a bright future ahead of her, and it is quite obvious that what she has been through has pushed her forward and made her more compassionate. Her compassion for the field of medicine is so obvious,” Abbe added.

More information about SignatureCare Emergency Center is available at https://ercare24.com. To apply for SignatureCare Emergency Center Medical and Health Scholarship, go to our scholarship page.

About SignatureCare Emergency Center

Houston, TX-based SignatureCare Emergency Center own 24-hour emergency centers throughout Texas, including nine ER locations in the Houston area (Montrose, Houston Heights, Cypress/FM 1960, Copperfield, Memorial City, Westchase, Bellaire, Mission Bend/Sugar Land, and Stafford), Atascocita/Humble, Killeen, Austin, College Station/Bryan, Paris, Midland, Odessa, Texarkana, Spring, Plano, and Lewisville, TX.

Share article on social media or email:

Placebo Response Mitigation Strategies & Tools for Optimizing Clinical Trials, Upcoming Webinar Hosted by Xtalks and Syneos Health


Applying these prognostic covariates significantly decrease the data variability and consequently improve the statistical analysis reducing the risk of trial failure.

This webinar will review available methods to mitigate the negative impact of the placebo response in clinical trials for therapies for diseases of the central nervous system. The featured speakers will discuss the origin and nature of the placebo response, the advantages and limitations of approaches to address the placebo response in drug development and how complementary solutions offered by Syneos Health® Clinical Surveillance & Training (CST) team and Cognivia® may be used in concert to maximize the benefits to trials.

The speakers will discuss strategies and tools for the management of placebo effects with a view to maximizing the clarity of efficacy signals.

Additionally, material presented will also cover the use of prognostic covariates (Placebell©™ covariates) developed specifically to predict the likelihood of placebo responsiveness of patients participating in a clinical trial. Placebell’s AI-powered algorithm calculates a placebo responsiveness score based on a sophisticated assessment of patient psychology, expectations and other factors. The use of patients’ psychology provides access to a, so far, unreached set of information so critical in phenomena like placebo response. Applying these prognostic covariates significantly decrease the data variability and consequently improve the statistical analysis reducing the risk of trial failure.

Combining the complementary approaches presented in this webinar would position sponsors for higher chances of success in mitigating the impact of the placebo response in clinical trials.

Register to learn about some of the key factors in mediating placebo response in clinical trials, including various mitigation strategies.

Join Dr. Veeraindar Goli, MD, MBA, DLFAPA, VP, Medical Affairs, Syneos Health; Dr. Luke Koschalka, PsyD, Sr. Clinical Scientist, Clinical Surveillance & Training, Syneos Health; and Dr. Dominique Demolle, PhD, CEO, Cognivia, for the live webinar on Monday, October 24, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Placebo Response Mitigation Strategies & Tools for Optimizing Clinical Trials.

ABOUT SYNEOS HEALTH

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs, and commercial capabilities to address modern market realities.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: